#Japan #AI Solutions #Veeva Systems #Tokyo #Clinical Trials

Veeva Japan Announces the Upcoming R&D and Quality Summit

On October 9, 2025, Veeva Japan will hold the highly anticipated 2025 Veeva R&D and Quality Summit at the Palace Hotel Tokyo. This premier event brings together leaders from the pharmaceutical sector to explore digital transformation (DX) and the latest trends affecting R&D and quality assurance in drug development.

As a subsidiary of Veeva Systems, a global pioneer in SaaS solutions that support the entire lifecycle of life sciences operations, Veeva Japan aims to provide attendees with valuable insights from industry experts. This year marks the summit's 12th iteration and promises participation from around 10 leading companies from both Japan and abroad. The sessions will feature cutting-edge announcements in artificial intelligence (AI) and will be organized across five key areas: Clinical Operations, Clinical Data, Regulatory Affairs, Quality Management, and Safety Information.

Featured Highlights

The Opening Keynote

The summit will kick off with an opening keynote delivered by Avril England, who oversees the Development Cloud product line at Veeva Systems, alongside Asia's R&D and Quality General Manager, Chris Shim. Together with Yoshinori Shimada, who leads Veeva Japan's local R&D and Quality division, they will discuss the latest advancements in AI technology, product highlights, and future roadmaps.

Insightful Sessions

1. CNS Pharmaceuticals and Veeva Clinical Integration
In this session, Yushi Kanda from Chugai Pharmaceutical will share experiences from the implementation of Veeva Clinical in 2024. Attendees can look forward to insights on collaboration with Roche, transitioning from legacy systems, employee engagement, and the role of IT teams in overcoming challenges during the integration process. This talk will shed light on both internal dynamics and external collaborations that facilitated the successful adoption of this new system.

2. Veeva Safety: The Future of AI and Automation in Pharmacovigilance
Managing drug safety information can be a daunting task for many companies. This session will delve into how Veeva Safety collaborates with AI tools and other Veeva products like Safety-EDC to enhance efficiency and optimize operations. Presenters Mami Yoshikawa from Veeva Systems and Daichi Akiyama from Veeva Japan will offer concrete approaches to overcoming common challenges in safety management processes.

Event Overview

• - Date: October 9, 2025
• - Time: 11:00 AM - 6:30 PM
• - Venue: Palace Hotel Tokyo, 1-1 Marunouchi, Chiyoda City, Tokyo
• - Target Audience: Professionals in the R&D departments of pharmaceutical companies
• - Registration: Free registration available through Veeva Japan's event-specific webpage.

For additional information and updates on Veeva, follow us on LinkedIn: Veeva Japan LinkedIn.

About Veeva Systems

Veeva Systems is dedicated to delivering cloud solutions tailored to the life sciences industry, emphasizing innovation, outstanding products, and customer success. Serving more than 1,500 organizations, from leading global biopharmaceutical firms to emerging biotech companies, Veeva maintains its commitment as a Public Benefit Corporation to balance the interests of customers, employees, shareholders, and the broader industry it serves. For more details, visit Veeva Japan.

This announcement may contain forward-looking statements related to Veeva’s products and their anticipated outcomes, which are subject to risks and uncertainties that could cause actual results to differ significantly. For more information on these risks, refer to our Form 10-Q filing from April 30, 2025, accessible at sec.gov.